SEC Form 4 · accession 0001209191-15-081102
LEMAITRE VASCULAR INC · LMAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence J Jasinski
Director
Period of report
Nov 16, 2015
Accepted (ET)
Nov 18, 2015 · 7:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001158895
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 16, 2015 | M | 7,500 | $6.23 | A | 21,613 | D | |
| Common StockF2 | Nov 16, 2015 | S | 7,500 | $13.5735 | D | 14,113 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $6.23 | Nov 16, 2015 | M | 7,500 | D | Jul 25, 2012 | Jul 25, 2017 | Common Stock | 7,500 | 0 | D |
Explanation of responses
- F1Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- F2The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $13.50 to $13.80. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- F3This option is fully vested and exercisable.